Methylphenidate alters NCS-1 expression in rat brain

Neurochemistry International

Volumn 53, Issue 1-2, 2008, Pages 12-16

  Souza, Renan P ^a,b   Soares, Eliane C ^b   Rosa, Daniela V F ^a,b   Souza, Bruno R ^a,b   Réus, Gislaine Z ^c   Barichello, Tatiana ^c   Gomes, Karin M ^c   Gomez, Marcus V ^b   Quevedo, João ^c   Romano Silva, Marco A ^a,b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Faculdade de Medicina   (Brazil)

^c UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

Author keywords

Dopamine receptor; Dopamine transporter; Methylphenidate; NCS 1; Rat brain; Sensitization

Indexed keywords

METHYLPHENIDATE; NEURONAL CALCIUM SENSOR; NEURONAL CALCIUM SENSOR 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENSITIZATION;

AGING; ANIMALS; BLOTTING, WESTERN; BRAIN CHEMISTRY; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBELLUM; DENSITOMETRY; DOSE-RESPONSE RELATIONSHIP, DRUG; METHYLPHENIDATE; NEURONAL CALCIUM-SENSOR PROTEINS; NEUROPEPTIDES; RATS; RATS, WISTAR;

MAMMALIA; RATTUS;

EID: 45849083129     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2008.04.007     Document Type: Article

References (43)

1. Amenta F., Cavallotti C., De M.M., Ricci A., and Vega J.-A. Changes of dopamine-sensitive cyclic AMP-generating system in the rat hippocampus as a function of age. Arch. Gerontol. Geriatr. 10 (1990) 279-285
2. Amenta F., Mignini F., Ricci A., Sabbatini M., Tomassoni D., and Tayebati S.-K. Age-related changes of dopamine receptors in the rat hippocampus: a light microscope autoradiography study. Mech. Age. Dev. 122 (2001) 2071-2083
3. Beaulieu J.-M., Gainetdinov R.-R., and Caron M.-G. The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends Pharmacol. Sci. 28 (2007) 166-172
4. Beavo J.-A., Bechtel P.-J., and Krebs E.-G. Activation of protein kinase by physiological concentrations of cyclic AMP. Proc. Natl. Acad. Sci. 71 (1974) 3580-3583
5. Bergson C., Levenson R., Goldman-Rakic P.-S., and Lidow M.-S. Dopamine receptor-interacting proteins: the Ca(2+) connection in dopamine signaling. Trends Pharmacol. Sci. 24 (2003) 486-492
6. Bradford M.-M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
7. Brown J.-M., Hanson G.-R., and Fleckenstein A.-E. Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants. J. Pharmacol. Exp. Therapeut. 296 (2001) 762-767
8. Cantwell D.-P. Attention deficit disorder: a review of the past 10 years. J. Am. Acad. Child Adol. Psych. 35 (1996) 978-987
9. Fisher S.-E., Francks C., McCracken J.-T., McGough J.-J., Marlow A.-J., MacPhie I.-L., Newbury D.-F., Crawford L.-R., Palmer C.-G., Woodward J.-A., Del'Homme M., Cantwell D.-P., Nelson S.-F., Monaco A.-P., and Smalley S.-L. A genomewide scan for loci involved in attention-deficit/hyperactivity disorder. Am. J. Human Genet. 70 (2002) 1183-1196
10. Fukui R., Svenningsson P., Matsuishi T., Higashi H., Nairn A.-C., Greengard P., and Nishi A. Effect of methylphenidate on dopamine/DARPP signalling in adult, but not young, mice. J. Neurochem. 87 (2003) 1391-1401
11. Genin A., Davis S., Meziane H., Doyere V., Jeromin A., Roder J., Mallet J., and Laroche S. Regulated expression of the neuronal calcium sensor-1 gene during long-term potentiation in the dentate gyrus in vivo. Neuroscience 106 (2001) 571-577
12. Gomez M., De Castro E., Guarin E., Sasakura H., Kuhara A., Mori I., Bartfai T., Bargmann C.-I., and Nef P. Ca2+ signaling via the neuronal calcium sensor-1 regulates associative learning and memory in C. elegans. Neuron 30 (2001) 241-248
13. Henry D.-J., Hu X.-T., and White F.-J. Adaptations in the mesoaccumbens dopamine system resulting from repeated administration of dopamine D1 and D2 receptor-selective agonists: relevance to cocaine sensitisation. Psychopharmacology (Berl) 140 (1998) 233-242
14. Kabbani N., Negyessy L., Lin R., Goldman-Rakic P., and Levenson R. Interaction with neuronal calcium sensor NCS-1 mediates desensitization of the D2 dopamine receptor. J. Neurosci. 22 (2002) 8476-8486
15. Kalivas P.-W., and Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Brain Res. Rev. 16 (1991) 223-244
16. Koh P.-O., Undie A.-S., Kabbani N., Levenson R., Goldman-Rakic P.-S., and Lidow M.-S. Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients. Proc. Natl. Acad. Sci. 100 (2003) 313-317
17. Kuczenski R., and Segal D.-S. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J. Neurochem. 68 (1997) 2032-2037
18. Kuribara H., and Uchihashi Y. Effects of haloperidol on the methamphetamine sensitization: assessment by ambulatory activity in mice. Jpn. J. Psychiatry Neurol. 47 (1993) 661-668
19. Li Q., Lu G., Antonio G.-E., Mak Y.-T., Rudd J.-A., Fan M., and Yew D.-T. The usefulness of the spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain. Neurochem. Int. 50 (2007) 848-857
20. Martins M.-R., Reinke A., Petronilho F.-C., Gomes K.-M., Dal-Pizzol F., and Quevedo J. Methylphenidate treatment induces oxidative stress in young rat brain. Brain Res. 1078 (2006) 189-197
21. Meng Z.-H., Feldpaush D.-L., and Merchant K.-M. Clozapine and haloperidol block the induction of behavioral sensitization to amphetamine and associated genomic responses in rats. Brain Res. Mol. Brain Res. 61 (1998) 39-50
22. Meririnne E., Kankaanpaa A., and Seppala T. Rewarding properties of methylphenidate: sensitization by prior exposure to the drug and effects of dopamine D1- and D2-receptor antagonists. J. Pharmacol. Exp. Therapeut. 298 (2001) 539-550
23. Pongs O., Lindemeier J., Zhu X.-R., Theil T., Engelkamp D., Krah-Jentgens I., Lambrecht H.-G., Koch K.-W., Schwemer J., and Rivosecchi R. Frequenin-a novel calcium-binding protein that modulates synaptic efficacy in the Drosophila nervous system. Neuron 11 (1993) 15-28
24. Reis H.-J., Rosa D.-V., Guimarães M.-M., Souza B.-R., Barros A.-G., Pimenta F.-J., Souza R.-P., Torres K.-C., and Romano-Silva M.-A. Is DARPP-32 a potential therapeutic target?. Expert Opin. Ther. Targets 11 (2007) 1649-1661
25. Robinson T.-E., and Berridge K.-C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Brain Res. Rev. 18 (1993) 247-291
26. Rosa D.-V., Souza R.-P., Souza B.-R., Motta B.-S., Caetano F., Jornada L.-K., Feier G., Jeromin A., Gomez M.-V., Quevedo J., and Romano-Silva M.-A. NCS-1 expression in rat brain after electroconvulsive stimulation. Neurochem. Res. 32 (2007) 81-85
27. Rosa D.-V., Souza R.-P., Souza B.-R., Motta B.-S., Caetano F., Jornada L.-K., Feier G., Gomez M.-V., Quevedo J., and Romano-Silva M.-A. DARPP-32 expression in rat brain after electroconvulsive stimulation. Brain Res. 1179 (2007) 35-41
28. Sandoval V., Riddle E.-L., Hanson G.-R., and Fleckenstein A.-E. Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors. J. Neurosci. 22 (2002) 8705-8710
29. Scahill L., and Schwab-Stone M. Epidemiology of ADHD in school-age children. Child Adol. Psych. Clin. North Am. 9 (2000) 541-555
30. Schaad N.-C., De Castro E., Nef S., Hegi S., Hinrichsen R., Martone M.-E., Ellisman M.-H., Sikkink R., Rusnak F., Sygush J., and Nef P. Direct modulation of calmodulin targets by the neuronal calcium sensor NCS-1. Proc. Natl. Acad. Sci. 93 (1996) 9253-9258
31. Souza B.-R., Souza R.-P., Rosa D.-V., Guimaraes M.-M., Correa H., and Romano-Silva M.-A. Dopaminergic intracellular signal integrating proteins: relevance to schizophrenia. Dial. Clin. Neurosci. 8 (2006) 95-100
32. Souza B.-R., Motta B.-S., Rosa D.-V., Torres K.-C., Castro A.-A., Comim C.-M., Sampaio A.-M., Lima F.-F., Jeromin A., Quevedo J., and Romano-Silva M.-A. DARPP-32 and NCS-1 expression is not altered in brains of rats treated with typical or atypical antipsychotics. Neurochem. Res. 33 (2008) 533-538
33. Stoof J.-C., and Kebabian J.-W. Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 294 (1981) 366-368
34. Svenningsson P., Tzavara E.-T., Carruthers R., Rachleff I., Wattler S., Nehls M., McKinzie D.-L., Fienberg A.-A., Nomikos G.-G., and Greengard P. Diverse psychotomimetics act through a common signaling pathway. Science 302 (2003) 1412-1415
35. Tarazi F.-I., Tomasini E.-C., and Baldessarini R.-J. Postnatal development of dopamine D1-like receptors in rat cortical and striatolimbic brain regions: an autoradiographic study. Dev. Neurosci. 21 (1999) 43-49
36. Turner K.-M., Burgoyne R.-D., and Morgan A. Protein phosphorylation and the regulation of synaptic membrane traffic. Trends Neurosci. 22 (1999) 459-464
37. Venero J.-L., de la R.C., Machado A., and Cano J. Age-related changes on monoamine turnover in hippocampus of rats. Brain Res. 631 (1993) 89-96
38. Volkow N.-D., Fowler J.-S., Wang G.-J., Logan J., Schlyer D., MacGregor R., Hitzemann R., and Wolf A.-P. Decreased dopamine transporters with age in health human subjects. Ann. Neurol. 36 (1994) 237-239
39. Volkow N.-D., Wang G.-J., Fowler J.-S., Gatley S.-J., Logan J., Ding Y.-S., Hitzemann R., and Pappas N. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am. J. Psychiatry 155 (1998) 1325-1331
40. Volkow N.-D., Wang G.-J., Fowler J.-S., and Ding Y.-S. Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder. Biol. Psychiatry 57 (2005) 1410-1415
41. Wightman B., Ebert B., Carmean N., Weber K., and Clever S. The C. elegans nuclear receptor gene fax-1 and homeobox gene unc-42 coordinate interneuron identity by regulating the expression of glutamate receptor subunits and other neuron-specific genes. Dev. Biol. 287 (2005) 74-85
42. Wilens T.-E., and Biederman J. The stimulants. Psych. Clin. North Am. 15 (1992) 191-222
43. Wooters T.-E., Dwoskin L.-P., and Bardo M.-T. Age and sex differences in the locomotor effect of repeated methylphenidate in rats classified as high or low novelty responders. Psychopharmacology (Berl) 188 (2006) 18-27